×

Get the Prostate Cancer Patient Guide as a digital download or free mailed copy.

Click here.

08/15/2022

From the Prostate Cancer Research Desk: Benefits of COVID-19 Vaccines, PSA Screening

In this roundup of recent prostate cancer research, data from the U.S. Veterans Health Administration yields insights into the benefits of COVID-19 vaccination and of PSA screening. COVID-19 vaccination protects patients with cancer against infection and death In case you needed another reason to get a COVID-19 vaccine or booster,. Read More

08/15/2022

Easy Fish Tacos

As the heat of summer continues, it’s a good time to leave the oven off and opt for a quick, healthy, stovetop-only dinner. This fish taco recipe allows you to make the fresh corn-and-cabbage slaw while the fish marinates in a simple, clean mix of olive oil, lime juice, and. Read More

08/05/2022

Breaking News: FDA Approves Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer

Today, the FDA approved darolutamide in combination with docetaxel chemotherapy for patients with metastatic hormone-sensitive prostate cancer (mHSPC). This means that patients with mHSPC (prostate cancer that has spread beyond the prostate and is responsive to hormone therapy, or who have not yet received hormone therapy) have an additional treatment. Read More

07/26/2022

Researchers Identify a New Subtype of Advanced Prostate Cancer

A PCF-funded study published in the prestigious journal Science has identified a new subtype of castration-resistant prostate cancer (CRPC). Understanding how genes and proteins “drive” this particular type of cancer may lead to new treatments. In the early stages, prostate cancer cells are driven by androgens (e.g., testosterone), which naturally. Read More

07/18/2022

Plant-Based Diets and Prostate Cancer

“Plant-based” foods are increasingly on the radar. You can grab a green juice at most chain coffee shops, a decent salad at airport restaurants, or a meat-free veggie burger at some locations of the major burger chains. And at many local grocery stores or farmers’ markets, you can purchase ingredients. Read More

07/11/2022

Meet Chuck Ryan, M.D.

“I don’t think we’ve ever been in a more exciting time in prostate cancer and oncology, with advances in targeted therapies, hormonal therapies, cellular therapies, radioligand therapies.  We don’t know what’s the next big thing, but we know that all of those approaches can be refined even further.  We’ve got. Read More

07/08/2022

Southwestern Black Bean and Corn Salad

It’s the peak of summer, bringing BBQs, potlucks, and family gatherings. If you’re looking for a quick and healthy recipe that you can easily scale up for a crowd, make this salad your go-to contribution for the rest of the season. This colorful mix of black beans, corn, onions, bell. Read More

07/07/2022

Home-based Exercise Programs for Cancer Survivors Show Promise

Exercise participation among cancer survivors has been shown to improve quality of life and physical functioning, yet only 10%-30% of survivors meet physical activity guidelines. In prostate cancer, aerobic exercise after prostate cancer diagnosis may reduce the risk of prostate cancer recurrence or death by up to 60 percent. Sedentary. Read More

07/05/2022

Robert & Susan Hollander Foundation Supports Prostate Cancer Research

When Dr. Robert Hollander was diagnosed with prostate cancer, he wanted to channel his passion for winemaking to support prostate cancer research. He is now preparing to launch new barrels of his small batch Zinfandel and Syrah wines while raising critical funding for PCF. Learn more at: https://www.indiegogo.com/projects/2redwines-supporting-prostate-cancer-research-2022#/ https://vimeo.com/735982616/3c95e0ab3a Read More

06/28/2022

Highlights from the American Society of Clinical Oncology 2022 Annual Meeting, Part 2

The American Society of Clinical Oncology (ASCO) held its Annual Meeting in Chicago in early June. PCF Young Investigator Eugene Shenderov, MD, of Johns Hopkins, presented early results of a new immunotherapy agent in localized prostate cancer. Patients diagnosed with intermediate- and high-risk prostate cancer have treatment options such as. Read More